Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Parfrey, PS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 88 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Middleton, RJ; Parfrey, PS; Foley, RN
      Left ventricular hypertrophy in the renal patient

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    2. Parfrey, PS
      Is renal insufficiency an atherogenic state? Reflections on prevalence, incidence, and risk

      AMERICAN JOURNAL OF KIDNEY DISEASES
    3. Hutchinson, JM; Jelinski, S; Hefferton, D; Desaulniers, G; Parfrey, PS
      Role of diagnostic labeling in antibiotic prescription

      CANADIAN FAMILY PHYSICIAN
    4. Beales, PL; Katsanis, N; Lewis, RA; Ansley, SJ; Elcioglu, N; Raza, J; Woods, MO; Green, JS; Parfrey, PS; Davidson, WS; Lupski, JR
      Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohortreveal a minor involvement of BBS6 and delineate the critical intervals ofother loci

      AMERICAN JOURNAL OF HUMAN GENETICS
    5. Slavotinek, AM; Stone, EM; Mykytyn, K; Heckenlively, JR; Green, JS; Heon, E; Musarella, MA; Parfrey, PS; Sheffield, VC; Biesecker, LG
      Mutations in MKKS cause Bardet-Biedl syndrome

      NATURE GENETICS
    6. Katsanis, N; Beales, PL; Woods, MO; Lewis, RA; Green, JS; Parfrey, PS; Ansley, SJ; Davidson, WS; Lupski, JR
      Mutations in MKKS cause obesity, retinal dystrophy and renal malformationsassociated with Bardet-Biedl syndrome

      NATURE GENETICS
    7. Foley, RN; Parfrey, PS; Kent, GM; Harnett, JD; Murray, DC; Barre, PE
      Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    8. Murphy, SW; Barrett, BJ; Parfrey, PS
      Contrast nephropathy

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    9. Parfrey, PS
      Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    10. Bianchi, G; London, GM; Marcelli, D; Massy, ZA; Parfrey, PS; Passlick-Deetjen, J; Rabelink, TJ; Wanner, C
      Clinical algorithms on cardiovascular risk factors in renal patients

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    11. Rigatto, C; Parfrey, PS
      Homocysteine and cardiovascular risk in dialysis patients

      PERITONEAL DIALYSIS INTERNATIONAL
    12. Murphy, ST; Parfrey, PS
      The impact of anemia correction on cardiovascular disease in end-stage renal disease

      SEMINARS IN NEPHROLOGY
    13. Foley, RN; Parfrey, PS; Morgan, J; Barre, PE; Campbell, P; Cartier, P; Coyle, D; Fine, A; Handa, P; Kingma, I; Lau, CY; Levin, A; Mendelssohn, D; Muirhead, N; Murphy, B; Plante, RK; Posen, G; Wells, GA
      Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy

      KIDNEY INTERNATIONAL
    14. Murphy, SW; Foley, RN; Barrett, BJ; Kent, GM; Morgan, J; Barre, P; Campbell, P; Fine, A; Goldstein, MB; Handa, SP; Jindal, KK; Levin, A; Mandin, H; Muirhead, N; Richardson, RMA; Parfrey, PS
      Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada

      KIDNEY INTERNATIONAL
    15. Murphy, SW; Foley, RN; Barrett, BJ; Kent, GM; Morgan, J; Barre, P; Campbell, P; Fine, A; Goldstein, MB; Handa, SP; Jindal, KK; Levin, A; Mandin, H; Muirhead, N; Richardson, RMA; Parfrey, PS
      Comparative mortality of hemodialysis and peritoneal dialysis in Canada

      KIDNEY INTERNATIONAL
    16. Rigatto, C; Foley, RN; Kent, GM; Guttmann, R; Parfrey, PS
      Long-term changes in left ventricular hypertrophy after renal transplantation

      TRANSPLANTATION
    17. Culleton, BF; Larson, MG; Parfrey, PS; Kannel, WB; Levy, D
      Proteinuria as a risk factor for cardiovascular disease and mortality in older people: A prospective study

      AMERICAN JOURNAL OF MEDICINE
    18. Murphy, ST; Parfrey, PS
      Erythropoietin therapy in chronic uremia: the impact of normalization of hematocrit

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    19. Parfrey, PS; Foley, RN
      The clinical epidemiology of cardiac disease in chronic renal failure

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    20. Parfrey, PS
      Cardiac disease in dialysis patients - Introduction

      SEMINARS IN DIALYSIS
    21. Parfrey, PS
      Pathogenesis of cardiac disease in dialysis patients

      SEMINARS IN DIALYSIS
    22. Foley, RN; Parfrey, PS
      Anemia as a risk factor for cardiac disease in dialysis patients

      SEMINARS IN DIALYSIS
    23. Woods, MO; Young, TL; Parfrey, PS; Hefferton, D; Green, JS; Davidson, WS
      Genetic heterogeneity of Bardet-Biedl syndrome in a distinct Canadian population: Evidence for a fifth locus

      GENOMICS
    24. Culleton, BF; Larson, MG; Wilson, PWF; Evans, JC; Parfrey, PS; Levy, D
      Cardiovascular disease and mortality in a community-based cohort with mildrenal insufficiency

      KIDNEY INTERNATIONAL
    25. Parfrey, PS; Foley, RN; Rigatto, C
      Risk issues in renal transplantation: Cardiac aspects

      TRANSPLANTATION PROCEEDINGS
    26. Culleton, BF; Larson, MG; Evans, JC; Wilson, PWF; Barrett, BJ; Parfrey, PS; Levy, D
      Prevalence and correlates of elevated serum creatinine levels - The Framingham heart study

      ARCHIVES OF INTERNAL MEDICINE
    27. Young, TL; Woods, MO; Parfrey, PS; Green, JS; Hefferton, D; Davidson, WS
      A founder effect in the Newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cM

      AMERICAN JOURNAL OF HUMAN GENETICS
    28. Young, TL; Penney, L; Woods, MO; Parfrey, PS; Green, JS; Hefferton, D; Davidson, WS
      A fifth locus for Bardet-Biedl syndrome maps to chromosome 2q31

      AMERICAN JOURNAL OF HUMAN GENETICS
    29. FOLEY RN; PARFREY PS
      CARDIOVASCULAR-DISEASE AND MORTALITY IN ESRD

      JN. Journal of nephrology
    30. GREGORY DM; WAY CY; HUTCHINSON TA; BARRETT BJ; PARFREY PS
      PATIENTS PERCEPTIONS OF THEIR EXPERIENCES WITH ESRD AND HEMODIALYSIS-TREATMENT

      Qualitative health research
    31. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; ODEA R; MURRAY DC; BARRE PE
      MODE OF DIALYSIS THERAPY AND MORTALITY IN END-STAGE RENAL-DISEASE

      Journal of the American Society of Nephrology
    32. FOLEY RN; PARFREY PS
      CARDIAC DISEASE IN THE DIABETIC DIALYSIS PATIENT

      Nephrology, dialysis, transplantation
    33. FOX GA; ODEA J; PARFREY PS
      CORONARY-ARTERY BYPASS GRAFT-SURGERY IN NEWFOUNDLAND AND LABRADOR

      CMAJ. Canadian Medical Association journal
    34. FOLEY RN; PARFREY PS; SARNAK MJ
      CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR-DISEASE IN CHRONIC RENAL-DISEASE

      American journal of kidney diseases
    35. MURPHY SW; FOLEY RN; PARFREY PS
      SCREENING AND TREATMENT FOR CARDIOVASCULAR-DISEASE IN PATIENTS WITH CHRONIC RENAL-DISEASE

      American journal of kidney diseases
    36. ODEA DF; MURPHY SW; HEFFERTON D; PARFREY PS
      HIGHER RISK FOR RENAL-FAILURE IN FIRST-DEGREE RELATIVES OF WHITE PATIENTS WITH END-STAGE RENAL-DISEASE - A POPULATION-BASED STUDY

      American journal of kidney diseases
    37. LEVEY AS; BETO JA; CORONADO BE; EKNOYAN G; FOLEY RN; KASISKE BL; KLAG MJ; MAILLOUX LU; MANSKE CL; MEYER KB; PARFREY PS; PFEFFER MA; WENGER NK; WILSON PWF; WRIGHT JT
      CONTROLLING THE EPIDEMIC OF CARDIOVASCULAR-DISEASE IN CHRONIC RENAL-DISEASE - WHAT DO WE KNOW - WHAT DO WE NEED TO LEARN - WHERE DO WE GO FROM HERE

      American journal of kidney diseases
    38. YOUNG TL; WOODS MO; PARFREY PS; GREEN JS; OLEARY E; HEFFERTON D; DAVIDSON WS
      CANADIAN BARDET-BIEDL-SYNDROME FAMILY REDUCES THE CRITICAL REGION OF BBS3 (3P) AND PRESENTS WITH A VARIABLE PHENOTYPE

      American journal of medical genetics
    39. FOLEY RN; PARFREY PS; KENT GM; HARNETT JD; MURRAY DC; BARRE PE
      LONG-TERM EVOLUTION OF CARDIOMYOPATHY IN DIALYSIS PATIENTS

      Kidney international
    40. BARRETT BJ; PARFREY PS; MORTON BC
      SAFETY AND CRITERIA FOR SELECTIVE USE OF LOW-OSMOLALITY CONTRAST FOR CARDIAC ANGIOGRAPHY

      Medical care
    41. CULLETON BF; LARSON MG; BARRETT BJ; PARFREY PS; LEVY D
      PREDICTORS OF AN ELEVATED SERUM CREATININE - THE FRAMINGHAM HEART-STUDY

      Journal of the American Society of Nephrology
    42. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      MORTALITY IN ESRD - THE RESCUE EFFECT OF SWITCHING FROM PD TO HEMODIALYSIS

      Journal of the American Society of Nephrology
    43. FOLEY RN; PARFREY PS; KENT GM
      EARLY AND LATE MORTALITY IN ESRD - HAZARDS OF THE COX MODEL

      Journal of the American Society of Nephrology
    44. YOUNG TL; WOODS MO; PARFREY PS; HEFFERTON D; GREEN JS; DAVIDSON WS
      GENETIC-HETEROGENEITY IN 16 NEWFOUNDLAND FAMILIES WITH BARDET-BIEDL-SYNDROME

      Journal of the American Society of Nephrology
    45. FOLEY RN; PARFREY PS
      COMMENTARY - CARDIOMYOPATHY OF ANEMIA AND THE POTENTIAL OF ERYTHROPOIETIN

      Peritoneal dialysis international
    46. PARFREY PS; FOLEY RN
      RISK-FACTORS FOR CARDIAC DYSFUNCTION IN DIALYSIS PATIENTS - IMPLICATIONS FOR PATIENT-CARE

      Seminars in dialysis
    47. BARRETT BJ; PARFREY PS; MORGAN J; BARRE P; FINE A; GOLDSTEIN MB; HANDA SP; JINDAL KK; KJELLSTRAND CM; LEVIN A; MANDIN H; MUIRHEAD N; RICHARDSON RMA
      PREDICTION OF EARLY DEATH IN END-STAGE RENAL-DISEASE PATIENTS STARTING DIALYSIS

      American journal of kidney diseases
    48. FOLEY RN; CULLETON BF; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      CARDIAC DISEASE IN DIABETIC END-STAGE RENAL-DISEASE

      Diabetologia
    49. DAVIDSON WS; JONES GJ; PARFREY PS; HEFFERTON D; GREEN JS; GUAYWOODFORD LM; YOUNG TL
      A NEWFOUNDLAND FAMILY NARROWS THE AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY-DISEASE (ARPKD) CRITICAL REGION ON 6P

      American journal of human genetics
    50. YOUNG TL; WOODS MO; PARFREY PS; HEFFERTON D; GREEN JS; DAVIDSON WS
      HOMOZYGOSITY MAPPING IN A CONSANGUINEOUS NEWFOUNDLAND KINDRED NARROWSTHE CRITICAL REGION OF BARDET-BIELD-SYNDROME ON 11Q (BBS1)

      American journal of human genetics
    51. CULLETON BF; FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      CARDIAC DISEASE IN DIABETIC-PATIENTS WITH ESRD

      Journal of the American Society of Nephrology
    52. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      MODE OF DIALYSIS, CARDIAC MORBIDITY AND MORTALITY IN ESRD

      Journal of the American Society of Nephrology
    53. ODEA DF; HARNETT J; HEFFERTON D; PARFREY PS
      FAMILIAL RISK OF END-STAGE RENAL-DISEASE IN A CAUCASIAN POPULATION

      Journal of the American Society of Nephrology
    54. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      HYPOALBUMINEMIA, CARDIAC MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE

      Journal of the American Society of Nephrology
    55. PARFREY PS; FOLEY RN; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      OUTCOME AND RISK-FACTORS FOR LEFT-VENTRICULAR DISORDERS IN CHRONIC UREMIA

      Nephrology, dialysis, transplantation
    56. PARFREY PS; COLLINGWOOD P; FOLEY RN; BAHRLE A
      LEFT-VENTRICULAR DISORDERS DETECTED BY M-MODE ECHOCARDIOGRAPHY IN CHRONIC UREMIA

      Nephrology, dialysis, transplantation
    57. CULLETON B; PARFREY PS
      CARDIOVASCULAR RISK IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS PATIENTS

      Peritoneal dialysis international
    58. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      THE IMPACT OF ANEMIA ON CARDIOMYOPATHY, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE

      American journal of kidney diseases
    59. PARFREY PS; FOLEY RN
      ISCHEMIC-HEART-DISEASE IN CHRONIC UREMIA

      Blood purification
    60. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; HU LQ; ODEA R; MURRAY DC; BARRE PE
      HYPOCALCEMIA, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE

      American journal of nephrology
    61. BUTLER JS; BARRETT BJ; KENT G; MCDONALD J; HAIRE R; PARFREY PS
      DETECTION AND CLASSIFICATION OF INAPPROPRIATE HOSPITAL STAY

      Clinical and investigative medicine
    62. BARRETT BJ; PARFREY PS; MCDONALD J; HAIRE R; PEACHEY G
      CONCURRENT UTILIZATION REVIEW AND INAPPROPRIATE HOSPITAL STAY - EVALUATION OF A PROGRAM

      Clinical and investigative medicine
    63. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      IMPACT OF HYPERTENSION ON CARDIOMYOPATHY, MORBIDITY AND MORTALITY IN END-STAGE RENAL-DISEASE

      Kidney international
    64. PARFREY PS; FOLEY RN; HARNETT JD; KENT GM; MURRAY D; BARRE PE
      OUTCOME AND RISK-FACTORS OF ISCHEMIC-HEART-DISEASE IN CHRONIC UREMIA

      Kidney international
    65. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      HYPERTENSION, CARDIOMYOPATHY, CARDIAC MORBIDITY AND MORTALITY IN ESRD

      Journal of the American Society of Nephrology
    66. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      HYPOALBUMINEMIA - A MAJOR RISK FACTOR FOR CARDIAC DISEASE IN ESRD

      Journal of the American Society of Nephrology
    67. PARFREY PS; HARNETT JD; KENT GM; ODEA R; MURRAY D; BARRE PE
      THE NATURAL-HISTORY OF UREMIC CARDIOMYOPATHY

      Journal of the American Society of Nephrology
    68. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      THE PROGNOSTIC IMPORTANCE OF LEFT-VENTRICULAR GEOMETRY IN UREMIC CARDIOMYOPATHY

      Journal of the American Society of Nephrology
    69. HARNETT JD; KENT GM; FOLEY RN; PARFREY PS
      CARDIAC-FUNCTION AND HEMATOCRIT LEVEL

      American journal of kidney diseases
    70. HARNETT JD; FOLEY RN; KENT GM; BARRE PE; MURRAY D; PARFREY PS
      CONGESTIVE-HEART-FAILURE IN DIALYSIS PATIENTS - PREVALENCE, INCIDENCE, PROGNOSIS AND RISK-FACTORS

      Kidney international
    71. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MARTIN CJ; MURRAY DC; BARRE PE
      CLINICAL AND ECHOCARDIOGRAPHIC DISEASE IN PATIENTS STARTING END-STAGERENAL-DISEASE THERAPY

      Kidney international
    72. PARFREY PS; HARNETT JD; FOLEY RN; KENT GM; MURRAY DC; BARRE PE; GUTTMANN RD
      IMPACT OF RENAL-TRANSPLANTATION ON UREMIC CARDIOMYOPATHY

      Transplantation
    73. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; HU LQ; MURRAY DC; BARRE PE
      CHRONIC HYPOCALCEMIA - A MAJOR MORBIDITY AND MORTALITY FACTOR IN ESRDPATIENTS

      Journal of the American Society of Nephrology
    74. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      LEFT-VENTRICULAR (LV) GEOMETRY - A CRITICAL PROGNOSTIC VARIABLE IN ESRD PATIENTS

      Journal of the American Society of Nephrology
    75. HARNETT JD; PARFREY PS; FOLEY RN; KENT GM; HU LQ; ODEA R; MURRAY DC; BARRE PE
      ISCHEMIC-HEART-DISEASE IN ESRD - PREVALENCE, PROGNOSIS AND RISK-FACTORS

      Journal of the American Society of Nephrology
    76. HARNETT JD; FOLEY RN; PARFREY PS; KENT GM; MURRAY D; BARRE PE
      THE EFFECT OF RENAL-TRANSPLANTATION ON CARDIAC-FUNCTION IN DIALYSIS PATIENTS

      Journal of the American Society of Nephrology
    77. HARNETT JD; KENT GM; BARRE PE; TAYLOR R; PARFREY PS
      RISK-FACTORS FOR THE DEVELOPMENT OF LEFT-VENTRICULAR HYPERTROPHY IN APROSPECTIVELY FOLLOWED COHORT OF DIALYSIS PATIENTS

      Journal of the American Society of Nephrology
    78. BARRETT BJ; PARFREY PS; FOLEY RN; DETSKY AS
      AN ECONOMIC-ANALYSIS OF STRATEGIES FOR THE USE OF CONTRAST-MEDIA FOR DIAGNOSTIC CARDIAC-CATHETERIZATION

      Medical decision making
    79. FOLEY RN; PARFREY PS; HEFFERTON D; SINGH I; SIMMS A; BARRETT BJ
      ADVANCE PREDICTION OF EARLY DEATH IN PATIENTS STARTING MAINTENANCE DIALYSIS

      American journal of kidney diseases
    80. HARNETT JD; PARFREY PS
      CARDIAC DISEASE IN UREMIA

      Seminars in nephrology
    81. PARFREY PS; HARNETT JD
      CLINICAL ASPECTS OF CARDIOMYOPATHY IN DIALYSIS PATIENTS

      Blood purification
    82. PARFREY PS
      CLINICAL EPIDEMIOLOGY IN CHRONIC UREMIA

      Clinical and investigative medicine
    83. PARFREY PS; GARDNER E; VAVASOUR H; HARNETT JD; MCMANAMON C; MCDONALD J; DAWE J
      THE FEASIBILITY AND EFFICACY OF EARLY DISCHARGE PLANNING INITIATED BYTHE ADMITTING DEPARTMENT IN 2 ACUTE-CARE HOSPITALS

      Clinical and investigative medicine
    84. BARRETT BJ; PARFREY PS
      PREVENTION OF NEPHROTOXICITY INDUCED BY RADIOCONTRAST AGENTS

      The New England journal of medicine
    85. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      LEFT-VENTRICULAR (LV) GEOMETRY - A CRITICAL PROGNOSTIC VARIABLE IN ESRD PATIENTS

      Clinical research
    86. HARNETT JD; PARFREY PS; KENT GM; FOLEY RN; BARRE PE
      CONGESTIVE-HEART-FAILURE (CHF) IN DIALYSIS PATIENTS - PREVALENCE, INCIDENCE, RISK-FACTORS AND PROGNOSIS

      Clinical research
    87. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
      ANEMIA AND RELATIVE HYPOTENSION ARE IMPORTANT RISK-FACTORS FOR DEATH IN DIALYSIS PATIENTS

      Clinical research
    88. HARNETT JD; MURPHY B; COLLINGWOOD P; PURCHASE L; KENT G; PARFREY PS
      THE RELIABILITY AND VALIDITY OF ECHOCARDIOGRAPHIC MEASUREMENT OF LEFT-VENTRICULAR MASS INDEX IN HEMODIALYSIS-PATIENTS

      Nephron


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 00:58:47